2023
Clinical Phenotyping with an Outcomes-driven Mixture of Experts for Patient Matching and Risk Estimation
Hurley N, Dhruva S, Desai N, Ross J, Ngufor C, Masoudi F, Krumholz H, Mortazavi B. Clinical Phenotyping with an Outcomes-driven Mixture of Experts for Patient Matching and Risk Estimation. ACM Transactions On Computing For Healthcare 2023, 4: 1-18. PMID: 37908872, PMCID: PMC10613929, DOI: 10.1145/3616021.Peer-Reviewed Original ResearchAssociation Between Psychosocial Risk Factors and Readmissions After Acute Myocardial Infarction: Role of COVID-19 Pandemic
Bansal K, Majmundar V, Muthyala A, Arun Kumar P, Dasari M, Kasireddy T, Yukselen Z, Singh T, Nakhla M, Anugu V, Desai N, Ganatra S, Dani S. Association Between Psychosocial Risk Factors and Readmissions After Acute Myocardial Infarction: Role of COVID-19 Pandemic. Current Problems In Cardiology 2023, 48: 101881. PMID: 37336310, PMCID: PMC10276487, DOI: 10.1016/j.cpcardiol.2023.101881.Peer-Reviewed Original ResearchConceptsAcute myocardial infarctionPsychosocial risk factorsRisk factorsCause readmissionMyocardial infarctionMultivariable hierarchical logistic regressionIndex acute myocardial infarctionCause-specific readmissionsCV risk factorsHeart failure readmissionNationwide Readmissions DatabaseWorse cardiovascular outcomesCOVID-19 time periodCOVID-19 pandemicHierarchical logistic regressionIndex admissionCardiovascular outcomesUnplanned readmissionSecondary outcomesPrimary outcomePrimary diagnosisHigh prevalenceReadmissionPatientsLogistic regression
2020
Low-Density Lipoprotein-Cholesterol Lowering in Patients with a Recent Myocardial Infarction and Subsequent Treatment with Evolocumab in Real-World Clinical Practice
Desai N, Xiang P, Exter J, Habib M, Wang X, Nunna S, Wade R, Mues K, Chen C. Low-Density Lipoprotein-Cholesterol Lowering in Patients with a Recent Myocardial Infarction and Subsequent Treatment with Evolocumab in Real-World Clinical Practice. Journal Of Clinical Lipidology 2020, 14: 551-552. DOI: 10.1016/j.jacl.2020.05.018.Peer-Reviewed Original Research1158-P: Cost-Effectiveness of Empagliflozin vs. Liraglutide as Second-Line Therapy for Type 2 Diabetes in the United States
REIFSNIDER O, PIMPLE P, STARGARDTER M, BRAND S, DESAI N, SHETTY S. 1158-P: Cost-Effectiveness of Empagliflozin vs. Liraglutide as Second-Line Therapy for Type 2 Diabetes in the United States. Diabetes 2020, 69 DOI: 10.2337/db20-1158-p.Peer-Reviewed Original ResearchBoehringer Ingelheim PharmaceuticalsUse of empagliflozinT2D patientsCardiovascular diseaseAdverse eventsUnited Kingdom Prospective Diabetes Study (UKPDS) risk equationsGLP-1 receptor agonistsT2D-related complicationsSecond-line therapyType 2 diabetesClinical trial resultsTreatment-induced changesBackground metforminCVD subgroupsCV deathRenal outcomesHazard ratioClinical outcomesSGLT2 inhibitorsCVS CaremarkMyocardial infarctionReceptor agonistSpouse/partnerImproved outcomesDrug classesRECLASSIFICATION OF HOSPITAL PERFORMANCE USING THE EXCESS DAYS IN ACUTE CARE MEASURE VS. 30-DAY READMISSIONS FOR HEART FAILURE AND ACUTE MYOCARDIAL INFARCTION: IMPLICATIONS FOR THE HOSPITAL READMISSIONS REDUCTION PROGRAM
Wadhera R, Maddox K, Desai N, Vaduganathan M, Gilstrap L, Shen C, Yeh R. RECLASSIFICATION OF HOSPITAL PERFORMANCE USING THE EXCESS DAYS IN ACUTE CARE MEASURE VS. 30-DAY READMISSIONS FOR HEART FAILURE AND ACUTE MYOCARDIAL INFARCTION: IMPLICATIONS FOR THE HOSPITAL READMISSIONS REDUCTION PROGRAM. Journal Of The American College Of Cardiology 2020, 75: 865. DOI: 10.1016/s0735-1097(20)31492-3.Peer-Reviewed Original ResearchEPIDEMIOLOGY OF LIPOPROTEIN(A) AND ASSOCIATION WITH MYOCARDIAL INFARCTION AND STROKE IN A NATIONALLY REPRESENTATIVE COHORT
Brandt E, Mani A, Spatz E, Desai N, Nasir K. EPIDEMIOLOGY OF LIPOPROTEIN(A) AND ASSOCIATION WITH MYOCARDIAL INFARCTION AND STROKE IN A NATIONALLY REPRESENTATIVE COHORT. Journal Of The American College Of Cardiology 2020, 75: 3669. DOI: 10.1016/s0735-1097(20)34296-0.Peer-Reviewed Original Research
2016
HOSPITAL PERFORMANCE FOR ACUTE MYOCARDIAL INFARCTION WITH THE NCDR ACTION REGISTRY-GWTG “ALL-OR-NONE COMPOSITE MEASURE”: MORE OPPORTUNITIES FOR IMPROVEMENT
Desai N, Wang Y, Masoudi F, de Lemos J, Goyal A, Julien H, Dharmarajan K, Spatz E, Udell J, Bhatt D, Rumsfeld J, Curtis J. HOSPITAL PERFORMANCE FOR ACUTE MYOCARDIAL INFARCTION WITH THE NCDR ACTION REGISTRY-GWTG “ALL-OR-NONE COMPOSITE MEASURE”: MORE OPPORTUNITIES FOR IMPROVEMENT. Journal Of The American College Of Cardiology 2016, 67: 466. DOI: 10.1016/s0735-1097(16)30467-3.Peer-Reviewed Original Research
2015
National assessment of statin therapy for patients with acute myocardial infarction, 2001–11: insight from the China PEACE-Retrospective Acute Myocardial Infarction study
Zhang L, Li J, Li X, Nasir K, Zhang H, Wu Y, Hu S, Wang Q, Downing N, Desai N, Masoudi F, Spertus J, Krumholz H, Jiang L, Group O. National assessment of statin therapy for patients with acute myocardial infarction, 2001–11: insight from the China PEACE-Retrospective Acute Myocardial Infarction study. The Lancet 2015, 386: s42. DOI: 10.1016/s0140-6736(15)00623-6.Peer-Reviewed Original ResearchIntensive statin therapyAcute myocardial infarctionAcute Myocardial Infarction StudyStatin therapyMyocardial Infarction StudyMyocardial infarctionStatin useCardiovascular diseaseLow-density lipoprotein cholesterolStatin therapy useLong-term mortalityUse of statinsNumber of patientsTwo-stage random sampling designMultilevel logistic regression modelsCochran-Armitage testLogistic regression modelsWestern rural regionStatin regimensEligible patientsHospital mortalityLipoprotein cholesterolFamily Planning CommissionIntensive therapyTherapy useSOCIOECONOMIC DISPARITIES AND QUALITY OF IN-HOSPITAL CARE AFTER MYOCARDIAL INFARCTION IN THE NATIONAL CARDIOVASCULAR DATA REGISTRY
Udell J, Desai N, Li S, Thomas L, Zhang W, de Lemos J, Roe M, Bhatt D. SOCIOECONOMIC DISPARITIES AND QUALITY OF IN-HOSPITAL CARE AFTER MYOCARDIAL INFARCTION IN THE NATIONAL CARDIOVASCULAR DATA REGISTRY. Journal Of The American College Of Cardiology 2015, 65: a21. DOI: 10.1016/s0735-1097(15)60021-3.Peer-Reviewed Original Research